Agilent Technologies, Inc. (NYSE:A) Shares Purchased by Global Retirement Partners LLC

Global Retirement Partners LLC boosted its holdings in Agilent Technologies, Inc. (NYSE:A) by 3.2% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 2,570 shares of the medical research company’s stock after acquiring an additional 79 shares during the quarter. Global Retirement Partners LLC’s holdings in Agilent Technologies were worth $382,000 at the end of the most recent quarter.

Other large investors have also recently added to or reduced their stakes in the company. Crewe Advisors LLC increased its position in shares of Agilent Technologies by 114.8% during the 2nd quarter. Crewe Advisors LLC now owns 189 shares of the medical research company’s stock valued at $25,000 after purchasing an additional 101 shares during the period. Ridgewood Investments LLC acquired a new position in shares of Agilent Technologies during the 2nd quarter valued at $29,000. Ashton Thomas Private Wealth LLC acquired a new position in shares of Agilent Technologies during the 2nd quarter valued at $39,000. Riverview Trust Co acquired a new position in shares of Agilent Technologies during the 1st quarter valued at $41,000. Finally, Larson Financial Group LLC increased its position in shares of Agilent Technologies by 29,300.0% during the 1st quarter. Larson Financial Group LLC now owns 294 shares of the medical research company’s stock valued at $43,000 after purchasing an additional 293 shares during the period. 87.42% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Agilent Technologies

In related news, SVP Dominique Grau sold 9,990 shares of Agilent Technologies stock in a transaction on Thursday, September 26th. The stock was sold at an average price of $145.00, for a total transaction of $1,448,550.00. Following the completion of the sale, the senior vice president now owns 40,011 shares of the company’s stock, valued at approximately $5,801,595. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. In other Agilent Technologies news, SVP Dominique Grau sold 9,990 shares of the firm’s stock in a transaction dated Thursday, September 26th. The stock was sold at an average price of $145.00, for a total transaction of $1,448,550.00. Following the transaction, the senior vice president now directly owns 40,011 shares in the company, valued at $5,801,595. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Padraig Mcdonnell sold 1,958 shares of the firm’s stock in a transaction dated Thursday, August 22nd. The shares were sold at an average price of $145.00, for a total value of $283,910.00. Following the transaction, the chief executive officer now owns 24,118 shares in the company, valued at approximately $3,497,110. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 13,953 shares of company stock valued at $2,013,630. Insiders own 0.33% of the company’s stock.

Agilent Technologies Stock Performance

Shares of Agilent Technologies stock opened at $136.76 on Tuesday. The stock has a market cap of $39.90 billion, a PE ratio of 32.33, a price-to-earnings-growth ratio of 6.96 and a beta of 1.05. The business has a fifty day simple moving average of $141.05 and a 200-day simple moving average of $138.70. The company has a quick ratio of 1.37, a current ratio of 1.78 and a debt-to-equity ratio of 0.36. Agilent Technologies, Inc. has a 12 month low of $96.80 and a 12 month high of $155.35.

Agilent Technologies (NYSE:A) last issued its earnings results on Wednesday, August 21st. The medical research company reported $1.32 EPS for the quarter, topping the consensus estimate of $1.26 by $0.06. The business had revenue of $1.58 billion during the quarter, compared to analysts’ expectations of $1.56 billion. Agilent Technologies had a return on equity of 25.26% and a net margin of 21.75%. Agilent Technologies’s revenue was down 5.6% compared to the same quarter last year. During the same quarter last year, the firm posted $1.43 earnings per share. On average, sell-side analysts anticipate that Agilent Technologies, Inc. will post 5.24 EPS for the current fiscal year.

Agilent Technologies Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 23rd. Investors of record on Tuesday, October 1st will be given a dividend of $0.236 per share. The ex-dividend date of this dividend is Tuesday, October 1st. This represents a $0.94 dividend on an annualized basis and a yield of 0.69%. Agilent Technologies’s payout ratio is 22.22%.

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on the company. Stifel Nicolaus reiterated a “buy” rating and set a $151.00 price target on shares of Agilent Technologies in a research report on Monday, August 26th. Bank of America raised their price objective on Agilent Technologies from $140.00 to $147.00 and gave the stock a “neutral” rating in a research note on Thursday, August 22nd. TD Cowen raised their price objective on Agilent Technologies from $153.00 to $160.00 and gave the stock a “buy” rating in a research note on Thursday, August 22nd. Citigroup raised their price objective on Agilent Technologies from $150.00 to $165.00 and gave the stock a “buy” rating in a research note on Thursday, August 22nd. Finally, Evercore ISI raised their price objective on Agilent Technologies from $135.00 to $145.00 and gave the stock an “in-line” rating in a research note on Tuesday, October 1st. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and nine have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, Agilent Technologies currently has an average rating of “Moderate Buy” and an average price target of $144.36.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.